The long and winding road to antibody therapeutics

MAbs. 2010 Sep-Oct;2(5):459-60. doi: 10.4161/mabs.2.5.13088. Epub 2010 Sep 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adalimumab
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology
  • Biomedical Research / methods*
  • Biomedical Research / trends
  • Humans
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab